Vinzent Rolny
Novel concept to guide systolic heart failure medication by repeated biomarker testing-results from TIME-CHF in context of predictive, preventive, and personalized medicine
Davarzani N, Brunner-La Rocca H, Peeters R, Pfisterer M, Zaugg C, Rolny V, Block D, de Boer R, Suter T, Karel J, Smirnov E, Rickenbacher P, Maeder M, Sanders-van Wijk S, TIME-CHF Investigators. Novel concept to guide systolic heart failure medication by repeated biomarker testing-results from TIME-CHF in context of predictive, preventive, and personalized medicine. EPMA J 2018; 9:161-173.
13.05.2018Novel concept to guide systolic heart failure medication by repeated biomarker testing-results from TIME-CHF in context of predictive, preventive, and personalized medicine
13.05.2018EPMA J 2018; 9:161-173
Davarzani Nasser, Brunner-La Rocca Hans-Peter, Peeters Ralf, Pfisterer Matthias E, Zaugg Christian, Rolny Vinzent, Block Dirk, de Boer Rudolf A, Suter Thomas, Karel Joël, Smirnov Evgueni, Rickenbacher Peter, Maeder Micha, Sanders-van Wijk Sandra, TIME-CHF Investigators
Impact of worsening renal function related to medication in heart failure
Brunner-La Rocca H, Maeder M, Rickenbacher P, Tobler D, Pfisterer M, Krause F, Rolny V, Eurlings L, Knackstedt C, TIME‐CHF investigators. Impact of worsening renal function related to medication in heart failure. Eur J Heart Fail 2014; 17:159-68.
30.12.2014Impact of worsening renal function related to medication in heart failure
30.12.2014Eur J Heart Fail 2014; 17:159-68
Brunner-La Rocca Hans-Peter, Maeder Micha, Rickenbacher Peter, Tobler Daniel, Pfisterer Matthias E, Krause Friedemann, Rolny Vinzent, Eurlings Luc, Knackstedt Christian, TIME‐CHF investigators